217 related articles for article (PubMed ID: 28248800)
21. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.
Dima A; Jurcut C; Baicus C
Rheumatol Int; 2018 Jul; 38(7):1169-1178. PubMed ID: 29796907
[TBL] [Abstract][Full Text] [Related]
22. Increase of cytokine production by pulmonary artery endothelial cells induced by supernatants from monocytes stimulated with autoantibodies against U1-ribonucleoprotein.
Okawa-Takatsuji M; Aotsuka S; Uwatoko S; Kinoshita M; Sumiya M
Clin Exp Rheumatol; 1999; 17(6):705-12. PubMed ID: 10609069
[TBL] [Abstract][Full Text] [Related]
23. Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.
Chevalier K; Chassagnon G; Leonard-Louis S; Cohen P; Dunogue B; Regent A; Thoreau B; Mouthon L; Chaigne B
J Autoimmun; 2024 Jun; 146():103220. PubMed ID: 38642508
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
[TBL] [Abstract][Full Text] [Related]
25. Mixed connective tissue disease.
Hoffman RW; Greidinger EL
Curr Opin Rheumatol; 2000 Sep; 12(5):386-90. PubMed ID: 10990174
[TBL] [Abstract][Full Text] [Related]
26. Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels.
Hajas A; Szodoray P; Barath S; Sipka S; Rezes S; Zeher M; Sziklai I; Szegedi G; Bodolay E
J Rheumatol; 2009 Sep; 36(9):1930-6. PubMed ID: 19684145
[TBL] [Abstract][Full Text] [Related]
27. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
[TBL] [Abstract][Full Text] [Related]
28. Cross-reactivity between autoimmune anti-U1 snRNP antibodies and neutralizing epitopes of HIV-1 gp120/41.
Douvas A; Takehana Y
AIDS Res Hum Retroviruses; 1994 Mar; 10(3):253-62. PubMed ID: 7517148
[TBL] [Abstract][Full Text] [Related]
29. Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients.
Paradowska-Gorycka A; Stypińska B; Olesińska M; Felis-Giemza A; Mańczak M; Czuszynska Z; Zdrojewski Z; Wojciechowicz J; Jurkowska M
HLA; 2016 Jan; 87(1):13-8. PubMed ID: 26818120
[TBL] [Abstract][Full Text] [Related]
30. [Mixed connective tissue disease: prevalence and clinical characteristics in African black, study of 7 cases in Gabon and review of the literature].
Missounga L; Ba JI; Nseng Nseng Ondo IR; Nziengui Madjinou MIC; Malekou D; Mouendou Mouloungui EG; Nzengue EE; Boguikouma JB; Kombila M
Pan Afr Med J; 2017; 27():162. PubMed ID: 28904690
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
Carpintero MF; Martinez L; Fernandez I; Romero AC; Mejia C; Zang YJ; Hoffman RW; Greidinger EL
Lupus; 2015 Sep; 24(10):1057-66. PubMed ID: 25736140
[TBL] [Abstract][Full Text] [Related]
32. 'Autoantibody dominance' pattern following idiotypic manipulation of naive mice by immunization with anti-U1RNP antibodies.
George J; Gilburd B; Levy Y; Afec A; Damianovich M; Ghirardello A; Doria A; Todesco S; Shoenfeld Y
Pathobiology; 1997; 65(4):204-9. PubMed ID: 9396044
[TBL] [Abstract][Full Text] [Related]
33. Doubtful Clinical Value of Subtyping Anti-U1-RNP Antibodies Regarding the RNP-70 kDa Antigen in Sera of Patients with Systemic Lupus Erythematosus.
Ahmad A; Brylid A; Dahle C; Saleh M; Dahlström Ö; Enocsson H; Sjöwall C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373545
[TBL] [Abstract][Full Text] [Related]
34. Raynaud's phenomenon in mixed connective tissue disease.
Grader-Beck T; Wigley FM
Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic challenge of patients with anti-U1-RNP antibodies.
Elhani I; Khoy K; Mariotte D; Comby E; Marcelli C; Le Mauff B; Audemard-Verger A; Boutemy J; Maigné G; Martin Silva N; Aouba A; de Boysson H
Rheumatol Int; 2023 Mar; 43(3):509-521. PubMed ID: 35896805
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
[TBL] [Abstract][Full Text] [Related]
37. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.
Vegh J; Szodoray P; Kappelmayer J; Csipo I; Udvardy M; Lakos G; Aleksza M; Soltesz P; Szilágyi A; Zeher M; Szegedi G; Bodolay E
Scand J Immunol; 2006 Jul; 64(1):69-76. PubMed ID: 16784493
[TBL] [Abstract][Full Text] [Related]
38. U1-70-kd autoantibody-positive mixed connective tissue disease in children. A longitudinal clinical and serologic analysis.
Hoffman RW; Cassidy JT; Takeda Y; Smith-Jones EI; Wang GS; Sharp GC
Arthritis Rheum; 1993 Nov; 36(11):1599-602. PubMed ID: 8240436
[TBL] [Abstract][Full Text] [Related]
39. Clinical and immunological profile in patients with mixed connective tissue disease.
Ahsan T; Erum U; Dahani A; Khowaja D
J Pak Med Assoc; 2018 Jun; 68(6):959-962. PubMed ID: 30323370
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease.
Zhang L; Visscher D; Rihal C; Aubry MC
Rheumatol Int; 2007 Oct; 27(12):1163-5. PubMed ID: 17520258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
